Value of reelin as parameter for monitoring hepatic fibrogenesis in a group of Egyptian HCV-infected patients

被引：0
|
作者：
Mansy, S.
Nosseir, M.
Zoheiry, M.
Othman, M.
Hassanein, M.
Guda, M.
Yehia, H.
Abotaleb, H.
机构：
来源：
JOURNAL OF VIRAL HEPATITIS | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients
    Mansy, Soheir S.
    Nosseir, Mona M.
    Zoheiry, Mona A.
    Hassanein, Moetaz H.
    Guda, Mohammed F.
    Othman, May M.
    AbuTalab, Hoda
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (09) : 1319 - 1328
  • [2] Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective
    El-Fishawy, Hussein
    Saadi, Gamal
    Hassaballa, May
    Hussein, Mohamed
    Doss, Wahid
    Ragab, Gaafar
    Barsoum, Rashad
    JOURNAL OF ADVANCED RESEARCH, 2016, 7 (03) : 391 - 402
  • [3] Safety of cyclosporin a in HCV-infected patients
    Galeazzi, Mauro
    Bellisai, Francesca
    Giannitti, Chiara
    Manganelli, Stefania
    Morozzi, Gabriella
    Sebastiani, Gian Domenico
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 544 - 549
  • [4] Impact of moderate alcohol consumption on hepatic fibrosis progression in HCV-infected patients
    Barjoan, E. Marine
    Gelsi, E.
    Delasalle, P.
    Ibragimova, N.
    Sattonnet, C.
    Saint-Paul, M. C.
    Gueyffier, C.
    Diebolt, E.
    Hayek, R.
    Fuzibet, J. G.
    Ouzan, D.
    Tran, A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S275 - S276
  • [5] THE CLINICAL AND ECONOMIC IMPACT OF HCV TREATMENT ON NON-HEPATIC CANCERS AMONG HCV-INFECTED PATIENTS
    Wang, W.
    Lo Re, V
    Guo, Y.
    Xiao, H.
    Brown, J.
    Park, H.
    VALUE IN HEALTH, 2019, 22 : S36 - S36
  • [6] IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients
    Elsayed, Heba Mosaad
    Nabiel, Yasmin
    Sheta, Tarek
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (02) : 123 - 133
  • [7] Tissue transglutaminase and hepatic fibrogenesis in HCV infected patients and in experimental mouse model.
    Iacono, OL
    Nardacci, R
    Ciccosanti, F
    Falasca, L
    Craxi, A
    Antonucci, G
    Ippolito, G
    Piacentini, M
    HEPATOLOGY, 2002, 36 (04) : 256A - 256A
  • [8] HCV-infected dialysis patients: History is changing
    Parlati, Lucia
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 225 - 227
  • [9] HEPATIC NUCLEAR RECEPTOR-MEDIATED PATHWAYS IN STEATOSIS AND FIBROSIS IN HCV-INFECTED PATIENTS
    Wu, Chuanghong
    Gilroy, Richard
    Damjanov, Ivan
    O'Neil, Maura
    Taylor, Ryan
    Wan, Yu-Jui Yvonne
    HEPATOLOGY, 2011, 54 : 1334A - 1334A
  • [10] Adherence to therapy: Challenges in HCV-infected patients
    Pozza R.
    Barakat F.
    Current Hepatitis Reports, 2007, 6 (4) : 160 - 168
12345